Literature DB >> 23053036

[Male sexuality in the elderly].

L Rinnab1, A J Schrader, M Schrader, F Zengerling.   

Abstract

Male sexuality in the elderly is an important issue with a growing relevance. In contrast to the assumption of an asexual state when becoming older, recent representative surveys show that the majority of men maintain sexual desires and fantasies into old age. Sexual activity primarily depends on the availability of a partner and on maintaining intimacy and sexuality in the face of changes in the sexual response cycle and increasing comorbidity. This review aims to clarify the normal aging process, the sexual behavior of aging males and the prevalence of sexual dysfunction.

Entities:  

Mesh:

Year:  2012        PMID: 23053036     DOI: 10.1007/s00120-012-2926-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  49 in total

1.  Decline of sexual function with age in Japanese men compared with American men--results of two community-based studies.

Authors:  N Masumori; T Tsukamoto; Y Kumamoto; L A Panser; T Rhodes; C J Girman; M M Lieber; S J Jacobsen
Journal:  Urology       Date:  1999-08       Impact factor: 2.649

Review 2.  The Ageing Male. A consensus statement from the joint multidisciplinary working group of the German Society of Andrology, the German Society of Dermatology, the German Society of Endocrinology and the German Society of Urology.

Authors:  W Weidner; H Behre; M Beutel; E Brähler; L Hertle; W Krause; G Ludwig; E Nieschlag; A Voigt; M P Wirth; K Schalkhäuser; G Popa
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

3.  Predictors and prevalence of erectile dysfunction in a racially diverse population.

Authors:  Christopher S Saigal; Hunter Wessells; Jennifer Pace; Matt Schonlau; Timothy J Wilt
Journal:  Arch Intern Med       Date:  2006-01-23

Review 4.  [Sexuality and pharmacotherapy. Medication-induced disorders of sexual response and pharmacotherapeutic options for the treatment of sexual dysfunctions].

Authors:  Uwe Hartmann; C Rüffer-Hesse
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2007-01       Impact factor: 1.513

5.  Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity.

Authors:  M H Blanker; J L Bosch; F P Groeneveld; A M Bohnen; A Prins; S Thomas; W C Hop
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

6.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

7.  The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size.

Authors:  C Sesti; V Florio; E G Johnson; R A Kloner
Journal:  Int J Impot Res       Date:  2006-07-20       Impact factor: 2.896

Review 8.  The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems.

Authors:  E R Schwarz; V Kapur; J Rodriguez; S Rastogi; S Rosanio
Journal:  Int J Impot Res       Date:  2006-06-08       Impact factor: 2.896

9.  A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction.

Authors:  Wayne J G Hellstrom; Matthew T Freier; Ege Can Serefoglu; Ronald W Lewis; Karen DiDonato; Craig A Peterson
Journal:  BJU Int       Date:  2012-07-12       Impact factor: 5.588

Review 10.  The pharmacological properties and therapeutic use of apomorphine.

Authors:  Samo Ribarič
Journal:  Molecules       Date:  2012-05-07       Impact factor: 4.411

View more
  1 in total

1.  [Sexuality of couples 5 years after radical prostatectomy. Sexuality of patients and their partners 1 year postoperatively in sexually active couples].

Authors:  T B Jordan; R Ernst; G Hatzichristodoulou; A Dinkel; T Klorek; C Beyrle; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.